M10.15
Lead-induced gout, hip
Clinical Classification Guidelines
Medical Intelligence & Overview
Lead-induced gout, also known as acute gouty arthritis caused by lead poisoning, is a specific form of gout that results from the toxic effects of lead buildup in the body. When this condition affects the hip joint, it leads to localized pain and inflammation. This condition falls under ICD-10 code M10.15 and is characterized by the accumulation of uric acid crystals in the joints due to lead exposure. Recognizing the signs and understanding the causes can help in timely management and prevention of severe joint damage.
Causes & Symptoms
Clinical Causes: Chronic exposure to lead, especially via occupational hazards such as mining, painting, or manufacturing Prolonged ingestion of lead-contaminated products or contaminated water Lead stored in bones and tissues affecting purine metabolism, leading to increased uric acid levels Genetic predisposition that may influence the severity of lead retention and toxin effects Pre-existing kidney impairment that exacerbates lead retention and uric acid buildup
Key Symptoms: Sudden and intense joint pain, often affecting the hip, knees, and fingers Swelling and tenderness around the affected joint Warmth and redness in the joint area Reduced joint mobility due to pain and swelling Signs of lead poisoning such as fatigue, abdominal pain, or anemia in some cases Persistent discomfort that may worsen with certain movements or pressure
Diagnostic & Treatment
Diagnosis Path: Blood tests to measure uric acid levels and detect elevated lead levels X-ray imaging to identify joint inflammation or joint damage Bone and tissue biopsies to assess lead deposits, if necessary Assessment of kidney function to rule out other contributing factors
Treatment Protocols: Discontinuing exposure to lead sources to prevent further poisoning Use of medications such as nonsteroidal anti-inflammatory drugs (NSAIDs) to reduce inflammation and pain Urinary chelating agents, like dimercaprol or penicillamine, to help remove lead from the body Medications to lower uric acid levels, such as allopurinol or febuxostat Supportive therapies like physical therapy to preserve joint function Monitoring and managing kidney health to prevent worsening of gout or lead toxicity
Clinical Advice & FAQs
Billing Guidance
Is M10.15 a billable ICD-10 code?
Yes, M10.15 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M10.15?
Clinical documentation must specify the nature of Lead-induced gout, hip and any associated comorbidities for accurate reporting.
Cite this Clinical Reference